Respiratory Syncytial Virus Infection (RSV)
PHCA is pleased to highlight Beyfortus, an important option for the prevention of respiratory syncytial virus (RSV). This treatment provides robust protection, particularly for infants and young children who are at increased risk for severe RSV infections, helping to reduce the impact of the virus during peak seasons. As part of its commitment to the health and safety of families, PHCA recommends and offers Beyfortus as a key component of its preventive care strategy. The following provides an overview of how Beyfortus works and its significance for patients.
read more





